With significant disparities in diagnosis, treatment, and funding when compared to men, women’s health has long been underserved. These gaps affect not only individual health outcomes, they also have societal and economic implications which are highlighted by a recent report by the World Economic Forum and The McKinsey Health Institute which addresses a $1 trillion dollar opportunity to improve lives and economies by mitigating these disparities.

Factors like societal perception, clinical practice, and financial investment all play an important part in women’s health. Addressing the gender health gap and overcoming issues like the misdiagnosis of diseases in women, increasing women’s representation in clinical trials, and advocating for greater financial investment in women’s health are all crucial steps in building a more equal healthcare system for all.

Today, we’re joined by board members of the World Economic Forum’s Global Alliance for Women’s Health to discuss how building a more equitable healthcare system can drive meaningful change, improve healthcare for women, and create access to significant economic potential worldwide.

In this episode, host Elisabeth Staudinger, Member of the Managing Board of Siemens Healthineers, is joined by fellow World Economic Forum’s Global Alliance for Women’s Health board members Nadia Fettah, Minister of Economy and Finance for the Government of Morocco and Shyam Bishen, Head of the Centre for Health & Healthcare at the World Economic Forum.

What you’ll learn in this episode:

• Despite living longer, women spend 25% more time in poor health than men
• Women are twice as likely to be misdiagnosed after having a heart attack than men. Along with misdiagnosis and premature discharge, female cardiac patients are also less likely to be prescribed secondary prevention measures after experiencing a cardiac event
• How the Global Alliance for Women's Health is pooling together efforts in research, regulation and funding to close the gender healthcare gap
• Success stories that give hope on the path to healthcare equality

Connect with Elisabeth Staudinger

• LinkedIn

Connect with Nadia Fettah

• LinkedIn

Connect with Shyam Bishen

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

Sepsis, originally known as blood poisoning, is a life-threatening medical emergency. Tune in to learn about the complexities of sepsis diagnosis, the role of lactate and procalcitonin levels, and the global health challenge it poses. Hear from experts and a sepsis survivor about the advancements in identifying and managing this critical condition.

Sepsis is the body’s extreme response to an infection. It occurs when a pre-existing infection triggers a chain reaction throughout a person's body. Sepsis can be difficult to diagnose because patients present different symptoms, and their observation can be subjective. According to the Global Sepsis Alliance, the disease contributes to approximately one in five deaths worldwide and in the United States alone; it stands as the leading cause of death in hospitals, leading to one in three hospital fatalities. Compounding these mortality rates is a rise in antibiotic and antimicrobial resistance due to overuse or misuse.

Today, we’re joined by experts in the field of diagnostics and critical care as well as a sepsis patient and advocate in order to more acutely understand the disease, its diagnosis, and the advancements in the field.

In this episode, host Ranga Sampath, Senior Vice President and Head of the Center for Innovation in Diagnostics at Siemens Healthineers and Member of the Board of the Sepsis Alliance, welcomes:

• Heike Spreter-Krick a sepsis survivor who is now a patient advocate working with the Global Sepsis Alliance
• Patti DeJuilio, Director of Respiratory Care and Diagnostic Services at Northwestern Medicine Central DuPage Hospital in Winfield, Illinois
• Dr. Eric Gluck, Director of Critical Care Services at Swedish Hospital and professor of medicine at Finch University of Health Sciences at The Chicago Medical School
• Mervyn Singer, professor of intensive care medicine at University College London

What you’ll learn in this episode:

• The timing of diagnosis and treatment is critical because sepsis creates oxygen deprivation in the cells.
• Risk factors like age and comorbidities can increase the likelihood of a patient developing sepsis.
• The biomarker procalcitonin can be used as an identifier for sepsis infection.
• Lactate levels, a chemical naturally produced by the body during times of stress, can be used as one indicator among others that a patient may be experiencing sepsis.
• In the UK, the National Early Warning Score helps closely monitor patients at risk for developing sepsis.
• IV antibiotics have long been the gold standard for sepsis treatment, but they are at risk of overuse and misuse.
• For many patients, surviving a sepsis infection is just the beginning of a long road to recovery.

Connect with Ranga Sampath

• LinkedIn

Connect with Heike Spreter-Krick

• Instagram

Connect with Patti DeJuilio

• LinkedIn

Connect with Mervyn Singer

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.

Regular exercise is one of the most effective methods to keep the heart healthy and efficient. In rare cases, however, there are reports of athletes collapsing mid-game due to cardiac arrest. And while exercise is generally also a key part of the rehabilitation process for those who’ve experienced cardiac events, caution should still be taken. This is where physician input is important, and where testing and regular monitoring can be implemented to reduce the risk of further events.

Today, we’re joined by experts in the fields of sports cardiology and exercise physiology, as well as an athlete with firsthand experience in the matter, to draw attention to the topic of cardiac health and how it pertains to sports medicine.

In this episode, host Myra Cocker, Assistant Professor of Cardiology at Houston Methodist Hospital and Global Director of Clinical Science for Cardiovascular Ultrasound at Siemens Healthineers, welcomes Dr. Jonathan Kim, Associate Professor and Founding Director at Emory University Sports Cardiology and Team Cardiologist for Georgia Tech, the Atlanta Falcons, Hawks, and Braves; as well as Dr. Dominique Hansen, Professor of Rehabilitation and Exercise Physiology in Cardiometabolic Diseases at Universiteit Hasselt in Belgium and Secretary of the European Association of Preventive Cardiology; and retired professional soccer player and cardiology patient Daniel Engelbrecht.

What you’ll learn in this episode:

• How cardiac risk can affect older and younger elite athletes differently
• Cardiac events can stem from myocarditis, caused by an infectious disease.
• Red flag symptoms when it comes to cardiac events while exercising, including intense chest pressure or loss of consciousness
• The use of Automated External Defibrillators is a critical first response strategy in the event of cardiac arrest.
• Implementation of an exercise program can be essential when treating a patient who has experienced, or is at risk for, cardiovascular disease.
• For patients who have suffered from major cardiac events, their timeline for return to sports or intense physical activity is heavily dependent on a number of individual factors.

Connect with Myra Cocker

• LinkedIn

Connect with Jonathan Kim

• LinkedIn

Connect with Dominique Hansen

• LinkedIn

Connect with Daniel Engelbrecht

• LinkedIn

Hosted on Acast. See acast.com/privacy for more information.